Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study

BACKGROUND: Therapeutic drug monitoring (TDM) aims to minimize the clinical impact of posaconazole and voriconazole pharmacokinetic variability. However, its benefits on clinical outcomes are still being defined. Additionally, TDM data are limited for posaconazole IV and delayed-release tablet formu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Whitley M., Schoeppler, Kelly E., Jaeger, Jaclyn, Mueller, Scott W., MacLaren, Robert, Fish, Douglas N., Kiser, Tyree H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594434/
https://www.ncbi.nlm.nih.gov/pubmed/28893246
http://dx.doi.org/10.1186/s12941-017-0235-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594434/
https://www.ncbi.nlm.nih.gov/pubmed/28893246
http://dx.doi.org/10.1186/s12941-017-0235-8

Ejemplares similares